bf/NASDAQ:PMCB_icon.png

NASDAQ:PMCB

PharmaCyte Biotech, Inc.

  • Stock

USD

Last Close

1.79

25/09 14:15

Market Cap

17.41M

Beta: −0.03

Volume Today

7.53K

Avg: 52.03K

PE Ratio

−38.42

PFCF: −7.57

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Apr '14
Apr '15
Apr '16
Apr '17
Apr '18
Apr '19
Apr '20
Apr '21
Apr '22
Apr '23
Apr '24
revenue
cost of revenue
gross profit
selling and marketing expenses
872.20K
-
230.50K
73.57%
general and administrative expenses
18.11M
-
9.99M
44.84%
4.67M
53.28%
3.26M
30.14%
4.98M
52.88%
3.64M
26.95%
3.53M
3.17%
2.71M
23.22%
3.70M
36.74%
5.99M
61.76%
2.12M
64.63%
selling general and administrative expenses
18.98M
-
10.22M
46.16%
4.67M
54.34%
3.26M
30.14%
4.98M
52.88%
3.64M
26.95%
3.53M
3.17%
2.71M
23.22%
3.70M
36.74%
5.99M
61.76%
2.12M
64.63%
research and development expenses
3.48M
-
1.41M
59.53%
1.18M
15.97%
2.00M
68.98%
460.05K
76.97%
301.22K
34.52%
916.25K
204.18%
690.94K
24.59%
468.54K
32.19%
407.43K
13.04%
other expenses
-5.89M
-
3.34M
156.62%
10.54K
99.68%
2.52M
23,762.42%
152.59K
93.93%
33.40K
78.11%
-40
100.12%
-1.19K
2,870%
-4.28K
260.52%
202.00K
4,816.37%
6.00M
2,867.92%
cost and expenses
18.98M
-
13.70M
27.84%
6.07M
55.66%
4.44M
26.86%
6.98M
57.16%
4.10M
41.26%
3.83M
6.69%
3.62M
5.32%
4.39M
21.23%
6.46M
46.98%
8.52M
31.98%
operating expenses
18.98M
-
13.70M
27.84%
6.07M
55.66%
4.44M
26.86%
6.98M
57.16%
4.10M
41.26%
3.83M
6.69%
3.62M
5.32%
4.39M
21.23%
6.46M
46.98%
8.52M
31.98%
interest expense
21.05K
-
-4.94K
123.46%
-1.19K
75.88%
-1.54K
29.22%
453
-
3.05K
572.41%
509
83.29%
ebitda
-24.87M
-
-13.20M
46.92%
-6.07M
54.00%
-4.44M
26.86%
-6.98M
57.16%
-4.10M
41.26%
-3.83M
6.69%
-3.62M
5.29%
-4.24M
16.96%
-4.32M
1.82%
-8.52M
97.41%
operating income
-18.98M
-
-13.70M
27.84%
-6.07M
55.66%
-4.44M
26.86%
-6.98M
57.16%
-4.10M
41.26%
-3.83M
6.69%
-3.62M
5.32%
-4.39M
21.23%
-6.46M
46.98%
-8.52M
31.98%
depreciation and amortization
-5.89M
-
492.05K
108.35%
152.59K
-
4.10K
97.31%
-40
100.98%
-1.19K
2,870%
153.36K
13,009.26%
2.14M
1,295.07%
total other income expenses net
-8.25M
-
2.85M
134.48%
10.54K
99.63%
-1.54K
114.60%
152.59K
10,014.75%
33.40K
78.11%
-493
101.48%
71.75K
14,652.74%
152.85K
113.05%
202.00K
32.15%
-8.72M
4,415.50%
income before tax
-27.25M
-
-10.85M
60.17%
-6.06M
44.14%
-4.44M
26.72%
-6.83M
53.68%
-4.07M
40.44%
-3.83M
5.91%
-3.55M
7.20%
-4.24M
19.37%
-4.32M
1.81%
-17.24M
299.38%
income tax expense
19.96K
-
4.94K
75.26%
-152.59K
-
-33.40K
78.11%
453
101.36%
3.05K
572.41%
-153.36K
5,134.87%
-1.94M
1,163.35%
net income
-27.25M
-
-10.85M
60.17%
-6.06M
44.14%
-4.44M
26.72%
-6.83M
53.68%
-4.07M
40.44%
-3.83M
5.90%
-3.55M
7.13%
-4.09M
14.95%
-4.32M
5.63%
-17.24M
299.38%
weighted average shs out
389.01K
-
469.79K
20.77%
501.60K
6.77%
563.54K
12.35%
645.76K
14.59%
733.40K
13.57%
903.81K
23.24%
1.45M
60.16%
15.52M
972.26%
19.49M
25.56%
9.58M
50.84%
weighted average shs out dil
389.01K
-
469.79K
20.77%
501.85K
6.83%
563.82K
12.35%
646.08K
14.59%
733.40K
13.51%
903.81K
23.24%
1.45M
60.16%
15.52M
972.26%
19.49M
25.56%
9.58M
50.84%
eps
-70.06
-
-23.11
67.01%
-12.08
47.73%
-7.88
34.77%
-10.57
34.14%
-5.55
47.49%
-4.23
23.78%
-2.46
41.84%
-0.26
89.43%
-0.22
15.38%
-1.80
718.18%
epsdiluted
-70.06
-
-23.11
67.01%
-12.08
47.73%
-7.88
34.77%
-10.57
34.14%
-5.55
47.49%
-4.23
23.78%
-2.46
41.84%
-0.26
89.43%
-0.22
15.38%
-1.80
718.18%

All numbers in USD (except ratios and percentages)